Loading organizations...
Loading organizations...
Clinical biotechnology company developing gene therapies using AAV vectors.
Freeline has raised $120.0M across 1 funding round.
Freeline has raised $120.0M in total across 1 funding round.
Freeline has raised $120.0M in total across 1 funding round.
Freeline's investors include Eventide Asset Management, Thomas Dyrberg, Wellington Management, Acorn Bioventures, Ample Plus Fund, Cowen Healthcare Investments.
Freeline has raised $120.0M across 1 funding round. Most recently, it raised $120.0M Series C Extension in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 5, 2020 | $120.0M Series C Extension | Eventide Asset Management, Thomas Dyrberg, Wellington Management | Acorn Bioventures, Ample Plus Fund, Cowen Healthcare Investments |